Title |
High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
|
---|---|
Published in |
BMC Complementary Medicine and Therapies, February 2014
|
DOI | 10.1186/1472-6882-14-46 |
Pubmed ID | |
Authors |
Felix H Fischer, George Lewith, Claudia M Witt, Klaus Linde, Klaus von Ammon, Francesco Cardini, Torkel Falkenberg, Vinjar Fønnebø, Helle Johannessen, Bettina Reiter, Bernhard Uehleke, Wolfgang Weidenhammer, Benno Brinkhaus |
Abstract |
The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens' needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public's health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 33% |
Australia | 2 | 22% |
Canada | 1 | 11% |
United Kingdom | 1 | 11% |
Spain | 1 | 11% |
Malta | 1 | 11% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 11% |
Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Scientists | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Spain | 1 | <1% |
Switzerland | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 176 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 32 | 18% |
Researcher | 21 | 12% |
Student > Bachelor | 21 | 12% |
Student > Ph. D. Student | 19 | 10% |
Student > Postgraduate | 12 | 7% |
Other | 45 | 25% |
Unknown | 31 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 28% |
Nursing and Health Professions | 20 | 11% |
Social Sciences | 13 | 7% |
Agricultural and Biological Sciences | 11 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 6% |
Other | 38 | 21% |
Unknown | 37 | 20% |